Dr. Susan Amelia Berry, MD

Dr. Berry practices at M Health Fairview University of Minnesota Medical Center in Minneapolis, Minnesota, part of M Health Fairview.

Dr. Berry's NPI, 1982640264, was assigned on June 22, 2006. Dr. Berry graduated from University of Kansas School of Medicine - Kansas City in 1978. Dr. Berry holds Minnesota license 26368.

Dr. Berry's primary practice is M Health Fairview University of Minnesota Medical Center, at 2450 Riverside Avenue, Minneapolis, MN 55454 in Hennepin County. The practice phone is (612) 624-1765.

Dr. Berry's primary practice is M Health Fairview University of Minnesota Medical Center in Minneapolis, Minnesota, part of M Health Fairview. The medical group on file is M Health Fairview Recovery Clinic. Dmand AI also links Dr. Berry to 4 more group practices and clinics, 3 medical groups and 1 dialysis center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Berry practices, 6 sites in all. Vendor and product names are available with a free account.

Clinical genetics (m.d.) is Dr. Berry's primary specialty in the NPI Registry, under taxonomy code 207SG0201X. Dr. Berry is board certified in clinical genetics by the American Board of Medical Genetics and Genomics. Dr. Berry is licensed in Minnesota.

Dmand AI lists chronic anemia and intellectual and developmental disabilities among the conditions Dr. Berry treats.

CMS data shows 17 Medicare services from Dr. Berry across 1 procedure code in 2024, all of them office visits, for 26 Medicare patients. Medicare paid $2,096 for them. Every service was in an office.

CMS counts 26 Medicare patients who saw Dr. Berry in 2024. 42% of them have mood disorders. Their average risk score is 2.44, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Berry's median patient age at 32, with 63% women.

In 2024, Dr. Berry wrote 235 Medicare Part D claims for 20 patients. 62% of them were for generic drugs. CMS names the drug for 230 of them, across 7 drugs with 11 or more claims each, at $4,419,272 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Dr. Berry for performance year 2024, reported as part of a group. Dr. Berry accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 108 papers to Dr. Berry, published from 2004 to 2024. 2018 was the busiest year, with 7. The most frequent topics are Neonatal Screening, RNA, Messenger and Liver. Dr. Berry has published most often in Genet Med. Dr. Berry's most frequent co-authors are Brendan H L Lee, MD, PhD, Ora Hirsch Pescovitz, MD and Georgianne Lee Arnold, MD.

Dmand AI links Dr. Berry to 4 clinical trials. 1 is still active or recruiting. Conditions studied include Urea Cycle Disorders, Inborn, Amino Acid Metabolism, Inborn Errors and Hyperammonemia. Open Payments lists research payments to Dr. Berry that name 1 trial.

CMS Open Payments shows 3 general payments to Dr. Berry from 1 drug or device company in 2025. Food and beverage make up the largest share, 100% of the total. Orchard Therapeutics North America paid the most, $210. It also lists 1 research payment totaling $2,000 in 2025, naming 1 clinical trial.

Dmand AI lists 1 award for Dr. Berry.

Dr. Berry graduated from University of Kansas School of Medicine - Kansas City in 1978.

Dr. Berry is in network with 17 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.